Jubilant Pharmova Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is OLMESARTAN MEDOXOMIL USP, with a corresponding US DMF Number 26929.
Remarkably, this DMF maintains an Active status since its submission on March 29, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 03, 2014, and payment made on April 01, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II